Diabetes

How pharmacists can support and advise patients during Ramadan

Pharmacists have an essential role in advising and counselling patients who are observing Ramadan. By understanding the possible compliance and adherence issues, pharmacists can support Muslim patients during this time.…

Meet the regional finalists of I Love My Pharmacist: Northern England

The public has until 21 July 2016 to vote for their favourite regional finalist of the 2016 I Love My Pharmacist Award. The pharmacist with the highest number of votes in each region will then meet with the judging panel who will decide the 2016 champion.…

Meet the regional finalists of I Love My Pharmacist: Southern England and the Channel Islands

The public has until 21 July 2016 to vote for their favourite regional finalist of the 2016 I Love My Pharmacist Award. The pharmacist with the highest number of votes in each region will then meet with the judging panel who will decide the 2016 champion.…

Meet the regional finalists of I Love My Pharmacist: Wales

The public has until 21 July 2016 to vote for their favourite regional finalist of the 2016 I Love My Pharmacist Award. The pharmacist with the highest number of votes in each region will then meet with the judging panel who will decide the 2016 champion.…

Meet the regional finalists of I Love My Pharmacist: Scotland

The public has until 21 July 2016 to vote for their favourite regional finalist of the 2016 I Love My Pharmacist Award. The pharmacist with the highest number of votes in each region will then meet with the judging panel who will decide the 2016 champion.…

What should the RPS do to ensure the professional autonomy of its members isn’t adversely affected by the working conditions imposed by employers?

Candidates explain what they think the Royal Pharmaceutical Society should do to ensure the professional autonomy of its members isn’t adversely affected by the working conditions imposed by employers.…

Insulin and metformin in combination cut mortality in type 2 diabetes

People with type 2 diabetes who take metformin with insulin have a reduced risk of major adverse cardiac events and death compared with those treated with insulin alone, according to a study carried out at Cardiff University and published in PLoS One on 6 May 2016.…

Risk of heart failure from saxagliptin and sitagliptin no higher than for other antidiabetics

New users of dipeptidyl peptidase-4 inhibitors saxagliptin and sitagliptin are not at increased risk of heart failure compared with users of other antidiabetic drugs, a study commissioned by the US Food and Drug Administration has found.…

Diabetes drugs with antioxidant properties linked to spread of cancer

Some recent treatments for diabetes may enhance the spread of cancer, suggest the results of a study conducted in mice.…

EMA to review canagliflozin over amputation risks

The European Medicines Agency has announced that it is reviewing the diabetes drug canagliflozin after an ongoing clinical trial found it may increase the rate of lower limb amputations.…